During the last session, Upstream Bio Inc (NASDAQ:UPB)’s traded shares were 0.32 million. At the end of the trading day, the stock’s price was $8.78, reflecting an intraday gain of 4.28% or $0.36. The 52-week high for the UPB share is $29.46, that puts it down -235.54 from that peak though still a striking 41.46% gain since the share price plummeted to a 52-week low of $5.14. The company’s market capitalization is $470.97M, and the average intraday trading volume over the past 10 days was 0.32 million shares, and the average trade volume was 258.83K shares over the past three months.
Upstream Bio Inc (NASDAQ:UPB) trade information
Upstream Bio Inc (UPB) registered a 4.28% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 4.28% in intraday trading to $8.78, hitting a weekly high. The stock’s 5-day price performance is 37.19%, and it has moved by 2.69% in 30 days. The short interest in Upstream Bio Inc (NASDAQ:UPB) is 3.9 million shares and it means that shorts have 16.06 day(s) to cover.
The consensus price target of analysts on Wall Street is $75, which implies an increase of 88.29% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $75 and $75 respectively. As a result, UPB is trading at a discount of -754.21% off the target high and -754.21% off the low.
Upstream Bio Inc (UPB) estimates and forecasts
In the rating firms’ projections, revenue will decrease -36.64% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 326.25k as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 352.75k by the end of current fiscal year.
While earnings are projected to return 57.00% in 2025, the next five years will return 23.56% per annum.
UPB Dividends
Upstream Bio Inc is due to release its next quarterly earnings on 2025-Mar-11. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Upstream Bio Inc (NASDAQ:UPB)’s Major holders
Upstream Bio Inc insiders own 19.80% of total outstanding shares while institutional holders control 87.78%, with the float percentage being 109.45%.
Also, the Mutual Funds coming in first place with the largest holdings of Upstream Bio Inc (UPB) shares are Fidelity Securities Fund-Fidelity Small Cap Growth Fund and Fidelity Select Portfolios-Health Care Portfolio . Data provided on Jan 31, 2025 indicates that Fidelity Securities Fund-Fidelity Small Cap Growth Fund owns about 1.23 shares. This amounts to just over 2.29 percent of the company’s overall shares, with a $10.77 million market value. The same data shows that the other fund manager holds slightly less at 853.67, or about 1.59% of the stock, which is worth about $7.5 million.
